Please note that these are **not** my functions.

Reference: *van Eijk RPA, Nikolakopoulos S, Roes KCB, et al. Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials (2019).*

Source : [reactive.tricals.org](http://reactive.tricals.org/)
